文献速递慢阻肺

PIC COPD+:慢阻肺合并多重共病患者的整合照护随机对照试验

Program of Integrated Care for Patients with Chronic Obstructive Pulmonary Disease and Multiple Comorbidities (PIC COPD+): a randomised controlled trial.
PubMed 文献 · Eur Respir J · 2018-01-11

本研究为两中心随机对照试验,纳入470例伴≥2种预后重要共病的慢阻肺患者,比较个案管理者主导的多组分急性加重预防/管理方案与常规照护。结果显示两组急诊就诊次数与住院次数无差异,但在曾就诊急诊者中干预组急诊风险更低(RR 0.74,95%CI 0.63-0.86),曾住院者住院风险更低(RR 0.69,95%CI 0.54-0.88),干预组死亡更少(21 vs 36,HR 0.56,95%CI 0.32-0.95)。

要点

  • 干预组与对照组急诊就诊次数、住院次数无显著差异。
  • 曾就诊急诊者中干预组急诊风险更低(RR 0.74,95%CI 0.63-0.86)。
  • 干预组死亡风险约为对照组一半(HR 0.56,95%CI 0.32-0.95)。

核心结论

  • 多组分、个案管理者主导的急性加重预防/管理模型未减少急诊就诊与住院,但干预组估计死亡风险接近对照组一半。

研究设计与样本

  • 两中心随机对照试验,纳入伴≥2种预后重要慢阻肺相关共病的患者470例(干预组236例,对照组234例)。
  • 干预包括个体化照护/行动计划与电话咨询(每12周一次,后改为每9个月一次),对照组接受常规照护。
  • 采用零膨胀泊松模型分析急诊就诊与住院,Cox比例风险模型分析死亡。

主要发现

  • 两组急诊就诊次数与住院次数无差异。
  • 在曾就诊急诊的患者中,干预组急诊就诊风险更低(RR 0.74,95%CI 0.63-0.86)。
  • 在需要住院的患者中,干预组住院风险更低(RR 0.69,95%CI 0.54-0.88)。
  • 干预组死亡21例,对照组36例(HR 0.56,95%CI 0.32-0.95)。
  • 其他次要结局(健康相关生活质量、慢阻肺严重度、慢阻肺自我效能、焦虑与抑郁)未见差异。

临床怎么用

  • 该模型可作为合并多重共病慢阻肺患者的个案管理选项,但需注意其主要未减少急诊与住院总次数。
  • 对曾发生急诊就诊或住院的高风险患者,该干预可能降低后续急诊与住院风险。
  • 干预组死亡风险降低的估计值需在临床决策中谨慎解读。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

We sought to evaluate the effectiveness of a multi-component, case manager-led exacerbation prevention/management model for reducing emergency department visits. Secondary outcomes included hospitalisation, mortality, health-related quality of life, chronic obstructive pulmonary disease (COPD) severity, COPD self-efficacy, anxiety and depression.Two-centre randomised controlled trial recruiting patients with ≥2 prognostically important COPD-associated comorbidities. We compared our multi-component intervention including individualised care/action plans and telephone consults (12-weekly then 9-monthly) with usual care (both groups). We used zero-inflated Poisson models to examine emergency department visits and hospitalisation; Cox proportional hazard model for mortality.We randomised 470 participants (236 intervention, 234 control). There were no differences in number of emergency department visits or hospital admissions between groups. We detected difference in emergency department visit risk, for those that visited the emergency department, favouring the intervention (RR 0.74, 95% CI 0.63-0.86). Similarly, risk of hospital admission was lower in the intervention group for those requiring hospital admission (RR 0.69, 95% CI 0.54-0.88). Fewer intervention patients died (21 versus 36) (HR 0.56, 95% CI 0.32-0.95). No differences were detected in other secondary outcomes.Our multi-component, case manager-led exacerbation prevention/management model resulted in no difference in emergency department visits, hospital admissions and other secondary outcomes. Estimated risk of death (intervention) was nearly half that of the control.

来源:Eur Respir J,查看原文。版权归原作者所有。

引用

  1. Rose L, Istanboulian L, Carriere L, et al. Program of Integrated Care for Patients with Chronic Obstructive Pulmonary Disease and Multiple Comorbidities (PIC COPD+): a randomised controlled trial. Eur Respir J. 2018. PMID: 29326330. doi:10.1183/13993003.01567-2017

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。